Regulation of Fibroblast Activation Protein by Transforming Growth Factor Beta-1 in Glioblastoma Microenvironment. 2021

Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
Laboratory of Cancer Cell Biology, Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University, 128 53 Prague 2, Czech Republic.

The proline-specific serine protease fibroblast activation protein (FAP) can participate in the progression of malignant tumors and represents a potential diagnostic and therapeutic target. Recently, we demonstrated an increased expression of FAP in glioblastomas, particularly those of the mesenchymal subtype. Factors controlling FAP expression in glioblastomas are unknown, but evidence suggests that transforming growth factor beta (TGFbeta) can trigger mesenchymal changes in these tumors. Here, we investigated whether TGFbeta promotes FAP expression in transformed and stromal cells constituting the glioblastoma microenvironment. We found that both FAP and TGFbeta-1 are upregulated in glioblastomas and display a significant positive correlation. We detected TGFbeta-1 immunopositivity broadly in glioblastoma tissues, including tumor parenchyma regions in the immediate vicinity of FAP-immunopositive perivascular stromal cells. Wedemonstrate for the first time that TGFbeta-1 induces expression of FAP in non-stem glioma cells, pericytes, and glioblastoma-derived endothelial and FAP+ mesenchymal cells, but not in glioma stem-like cells. In glioma cells, this effect is mediated by the TGFbeta type I receptor and canonical Smad signaling and involves activation of FAP gene transcription. We further present evidence of FAP regulation by TGFbeta-1 secreted by glioma cells. Our results provide insight into the previously unrecognized regulation of FAP expression by autocrine and paracrine TGFbeta-1 signaling in a broad spectrum of cell types present in the glioblastoma microenvironment.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D008565 Membrane Proteins Proteins which are found in membranes including cellular and intracellular membranes. They consist of two types, peripheral and integral proteins. They include most membrane-associated enzymes, antigenic proteins, transport proteins, and drug, hormone, and lectin receptors. Cell Membrane Protein,Cell Membrane Proteins,Cell Surface Protein,Cell Surface Proteins,Integral Membrane Proteins,Membrane-Associated Protein,Surface Protein,Surface Proteins,Integral Membrane Protein,Membrane Protein,Membrane-Associated Proteins,Membrane Associated Protein,Membrane Associated Proteins,Membrane Protein, Cell,Membrane Protein, Integral,Membrane Proteins, Integral,Protein, Cell Membrane,Protein, Cell Surface,Protein, Integral Membrane,Protein, Membrane,Protein, Membrane-Associated,Protein, Surface,Proteins, Cell Membrane,Proteins, Cell Surface,Proteins, Integral Membrane,Proteins, Membrane,Proteins, Membrane-Associated,Proteins, Surface,Surface Protein, Cell
D010450 Endopeptidases A subclass of PEPTIDE HYDROLASES that catalyze the internal cleavage of PEPTIDES or PROTEINS. Endopeptidase,Peptide Peptidohydrolases
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005455 Fluorescent Antibody Technique Test for tissue antigen using either a direct method, by conjugation of antibody with fluorescent dye (FLUORESCENT ANTIBODY TECHNIQUE, DIRECT) or an indirect method, by formation of antigen-antibody complex which is then labeled with fluorescein-conjugated anti-immunoglobulin antibody (FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT). The tissue is then examined by fluorescence microscopy. Antinuclear Antibody Test, Fluorescent,Coon's Technique,Fluorescent Antinuclear Antibody Test,Fluorescent Protein Tracing,Immunofluorescence Technique,Coon's Technic,Fluorescent Antibody Technic,Immunofluorescence,Immunofluorescence Technic,Antibody Technic, Fluorescent,Antibody Technics, Fluorescent,Antibody Technique, Fluorescent,Antibody Techniques, Fluorescent,Coon Technic,Coon Technique,Coons Technic,Coons Technique,Fluorescent Antibody Technics,Fluorescent Antibody Techniques,Fluorescent Protein Tracings,Immunofluorescence Technics,Immunofluorescence Techniques,Protein Tracing, Fluorescent,Protein Tracings, Fluorescent,Technic, Coon's,Technic, Fluorescent Antibody,Technic, Immunofluorescence,Technics, Fluorescent Antibody,Technics, Immunofluorescence,Technique, Coon's,Technique, Fluorescent Antibody,Technique, Immunofluorescence,Techniques, Fluorescent Antibody,Techniques, Immunofluorescence,Tracing, Fluorescent Protein,Tracings, Fluorescent Protein
D005909 Glioblastoma A malignant form of astrocytoma histologically characterized by pleomorphism of cells, nuclear atypia, microhemorrhage, and necrosis. They may arise in any region of the central nervous system, with a predilection for the cerebral hemispheres, basal ganglia, and commissural pathways. Clinical presentation most frequently occurs in the fifth or sixth decade of life with focal neurologic signs or seizures. Astrocytoma, Grade IV,Giant Cell Glioblastoma,Glioblastoma Multiforme,Astrocytomas, Grade IV,Giant Cell Glioblastomas,Glioblastoma, Giant Cell,Glioblastomas,Glioblastomas, Giant Cell,Grade IV Astrocytoma,Grade IV Astrocytomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines

Related Publications

Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
September 2002, Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery,
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
March 1995, The Journal of biological chemistry,
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
March 1994, Journal of immunology (Baltimore, Md. : 1950),
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
July 1988, Endocrinology,
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
January 1992, Cancer treatment and research,
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
June 1992, Journal of cell science,
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
March 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research,
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
April 2003, Journal of dermatological science,
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
July 1994, Experimental eye research,
Evzen Krepela, and Zdislava Vanickova, and Petr Hrabal, and Michal Zubal, and Barbora Chmielova, and Eva Balaziova, and Petr Vymola, and Ivana Matrasova, and Petr Busek, and Aleksi Sedo
November 2017, Rheumatology (Oxford, England),
Copied contents to your clipboard!